相似文献
1
Activated protein C (Xigris): a drug in trouble.
Acta Anaesthesiol Scand. 2007 Feb;51(2):261-2. doi: 10.1111/j.1399-6576.2006.01215.x.
2
Activated protein C (Xigris) treatment in sepsis: a drug in trouble.
Acta Anaesthesiol Scand. 2006 Sep;50(8):907-10. doi: 10.1111/j.1399-6576.2006.01086.x.
3
[Xigris--activated protein C].
Ugeskr Laeger. 2004 Mar 8;166(11):1002-4.
4
[Xigris and corticoids: what are the perspectives for the patient with severe sepsis?].
Ann Fr Anesth Reanim. 2003 Dec;22 Spec No 1:43-5.
5
Xigris: reducing mortality in adult patients with severe sepsis.
Urol Nurs. 2002 Jun;22(3):200-1.
6
The search for effective therapy for sepsis: back to the drawing board?
JAMA. 2011 Dec 21;306(23):2614-5. doi: 10.1001/jama.2011.1853.
7
Risks and benefits of activated protein C treatment for severe sepsis.
N Engl J Med. 2002 Sep 26;347(13):1027-30. doi: 10.1056/NEJMsb020574.
8
The Sepsis Saga: Consensus to Xigris.
Air Med J. 2016 Jul-Aug;35(4):194-6. doi: 10.1016/j.amj.2016.04.010. Epub 2016 Jun 3.
9
[Clinical experience with xigris].
Ann Fr Anesth Reanim. 2003 Dec;22 Spec No 1:46-7.
10
Criteria for use of drotrecogin alfa.
Am J Health Syst Pharm. 2004 Jan 15;61(2):203-4; author reply 204-5. doi: 10.1093/ajhp/61.2.203.
Zotero 插件